Observational Study Suggests that ARBs may be a better choice than ACE-inhibitors in Certain Elderly Heart Failure Patients

By | October 31, 2011

A team of researchers, including Center faculty member Thomas E. Love, Ph.D., reported important differences in the ways in which various heart failure drugs appear to work, depending on whether the patient has systolic or diastolic heart failure. A Reuters Health report on the study, which suggests that angiotensin receptor blockers (ARBs) may have an edge in some elderly heart failure patients over ACE-inhibitors, may be found at http://www.thedoctorschannel.com/go/reuters/4765.htmlhttp://www.thedoctorschannel.com/go/reuters/4765.html